Bank of New York Mellon Corp
Institutional investor · Portfolio as of Q2 2020
SEC EDGAR SourceSEC Filings
Bank of New York Mellon Corp manages $127.7M across 1 positions as of Q2 2020. Top holdings: HZNP (100.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3/5.0.
Q2 2020 Summary
Increased 1. Top move: HZNP (INCREASED, conviction 98). Portfolio: $128M across 1 positions.
Top holdings by portfolio weight
HZNP100.00%
Portfolio allocation by GICS sector
Unknown100.00%
Behavioral investing profile
7-dimension quality assessment
Solid(3.0 / 5.0)
Holdings1 positions
Activity:
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
HORIZON THERAPEUTICS PLC | 2.3M | $127.7M | 100.0% | — | — | 5 qtrssince 2019-Q2 | Increased 98 |
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Security
7Q
35473P553FRANKLIN TEMPLETON ETF TR
Q3 2024 → Q1 2026+1.9M shares+$40.5M
40
7Q
464288166ISHARES TR
Q3 2024 → Q1 2026+194,008 shares+$21.5M
35
7Q
46435U440ISHARES TR
Q3 2024 → Q1 2026+29,190 shares+$1.5M
28
Upgrade to Pro to see all accumulation streaks
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer